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Abstract⎯The secondary peptide metabolites produced by the Trichoderma asperellum strain F-1087 were
isolated, and their properties were studied. It has been shown these metabolites at concentrations of 0.08 and
0.02 mg/mL inhibit the human prostate cancer cell line by 97 and 34%, respectively.
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INTRODUCTION
The genus of fungi Trichoderma is widely distrib-
uted in different climatic zones; they occupy a variety
of habitats. These fungi can be isolated from a large
number of natural and artificial substrates [1, 2]. The
survival of these fungi in different climatic zones is
caused by their high adaptability, as well as the wide
metabolic variety of strains, their high reproductivity,
and their competitiveness [3].
Mycelial fungi, including molds, are effective pro-
ducers of secondary metabolites (products of the pro-
ducer’s vital activity) that possess biological activity and
influence the environment of the producer by suppress-
ing the growth of other microorganisms [4–7]. Many
secondary metabolites do not have a definite function
and are often synthesized under certain cultivation
conditions, for example, stressful ones [8, 9]. Some of
them are of interest to the pharmaceutical industry
(enzymes and antibiotics) [10, 11].
The purpose of this work was to isolate and charac-
terize the secondary peptide metabolites of the mold
fungus T. asperellum F-1087.
MATERIALS AND METHODS
The object of the study was the Trichoderma
asperellum F-1087 strain isolated from the soil of the
Murzikhinsky II burial ground (Republic of Tatarstan,
Russia). The strain was deposited in the All-Russia
Collection of Industrial Microorganisms under the
registration number F-1087.
To obtain the seeding material, the fungus
T. asperellum F-1087 was grown on Czapek nutrient
medium of the following composition (g/L): glucose
30, NaNO3 3.0, K2HPO4 1.0, MgSO4 ⋅ 7H2O 0.5, KCl
0.5, FeSO4 ⋅ 7H2O 0.01, and agar-agar 15. Cultivation
was carried out in the dark for 14 days at 28°C [12].
After 14 days of growth, the formation of a dark green
pigment was observed.
Mycelium with a portion of the solid medium was
placed in a liquid nutrient medium of the following
composition (g/L): glucose 5, KH2PO4 0.8, KNO3
0.7, CaCO3 0.06, MgSO4 0.5, ZnSO4 0.01, CuSO4
0.005, FeSO4 0.001, MnSO4 0.01 and distilled water
1 L; H3PO4 was added to a concentration of 1.75%;
and mycelium was cultured in 1000-mL conical f lasks
containing 500 mL of the medium for 12 days on a
Helicon shaker (Germany) at a platform rotation
speed of 80 rpm at 28°C. During cultivation of the fun-
gus, the product yield, the morphological state of the
culture, and the absence of extraneous microflora
were monitored.
After the cultivation was completed, the culture liq-
uid (CL) of T. asperellum F-1087 was separated by fil-
tration through a layer of gauze and centrifuged at
4800 g for 15 min. Ethyl acetate (Khimmed, Russia)
was poured onto the resulting supernatant in a 1 : 1
ratio, stirred, and incubated for 24 h at 4°C. In this
case, a clear separation of the boundaries of the two
phases was observed. The upper phase (ethyl acetate)
was evaporated to a volume of 1 mL on a Heidolph
vacuum rotary evaporator (Germany) for 4 h at 30°C
and then dissolved in 50 mL of acetonitrile (Merck,
Germany).
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Biuret and xantoprotein reactions (Mulder’s reac-
tion) were carried out to qualitatively identify metabo-
lites.
Metabolites were further purified by reversed-
phase high performance liquid chromatography (RP-
HPLC) with a Dionex chromatograph (United States)
on a C-18 Agilent column (United States), which was
conducted according to protocol [13]. The column
was equilibrated with acetonitrile for 10 min at a f low
rate of 0.4 mL/min, and the ethyl acetate phase (2 μL)
was then injected. The elution of the metabolites con-
tained therein was carried out with a concentration
gradient from 100% acetonitrile to 100% Milli-Q H2O
for 10 min at a f low rate of 0.4 L/min. Detection was
carried out at 220 nm, which corresponds to the max-
imum absorption of peptides. Two components were
collected and used for further characterization. The
collection of fractions was repeated 50 times to accu-
mulate a sufficient amount of metabolites.
The extracted metabolites were analyzed on a
Bruker mass spectrometer (United States) by the
MALDI-TOF/TOF method in MS mode. Positively
charged ions were evaluated in the reflex mode in the
range of 600–1500 m/z. For analysis, fractions after
HPLC were preconcentrated tenfold; 2 μL of the frac-
tion was mixed with 0.5 μL of a saturated matrix solu-
tion. A solution containing 30% 2,5-dihydroxybenzoic
acid, 69% acetonitrile, 5% water, and 0.5% trif luoro-
acetic acid served as a matrix.
The metabolic activity of peptide metabolites was
studied in the PC-3 cell lines (human prostate cancer
cells) [14]. The PC-3 cell lines were cultured in
α-MEM medium containing 10% phosphate buffer,
1 mM L-glutamine, 100 U/mL penicillin, and
100 μg/mL streptomycin, at 37°C in a CO2-incubator in
5% CO2 atmosphere, with replacement of the medium
every 3–4 days. The PC-3 cells (3 × 104 cells/mL) were
added to the wells of a 96-well plate. After 24 hours of
incubation, the nutrient medium was replaced with a
medium containing different amounts of isolated and
purified peptide metabolites. To do this, various con-
centrations of the metabolite were dissolved in aqueous
acetonitrile: 1.7, 0.08, 0.04, 0.02, 0.01, 0.005, 0.002,
0.001, 0.0006, and 0.0003 mg/mL. The amount of
aqueous acetonitrile in each well did not exceed 10% of
the total volume. Cells in the presence of metabolites
were incubated for 72 h at 37°C. The culture medium
was then replaced by a single phosphate buffered saline
(pH 7.4) containing 0.5 mg/mL 3-(4,5-dimethylthi-
azol-2-yl)-2,5-tetrazolium bromide (MTT). After
incubation in the medium containing MTT, dimethyl
sulfoxide was replaced to dissolve formazan, a product
of MTT reduction by viable cells, which was recorded
on a microplate reader (Tecan, Switzerland) at 555 nm
(maximum absorption of formazan) and adjusted for
plastic. Due to differences in the thickness of the bot-
tom of the wells, we used the maximum, taking into
account the absorption of plastic at 750 nm. The num-
ber of viable cells was calculated relative to control
(untreated cells). The amount of peptide metabolites
that inhibited cell growth by 50% relative to control
was taken as IC50. In the study of cytotoxicity against
the PC-3 cell line, the initial amount of the secondary
metabolite was 1.7 mg/mL. Survival of the PC-3 cell
lines was calculated by the formula optical adsorption
of peptide / mean value of optical adsorption of the
control.
RESULTS AND DISCUSSION
Metabolites were extracted from CL of T. asperel-
lum F-1087 with ethyl acetate; the components con-
tained in the extract were separated by RP-HPLC. In
this case, two components were detected (Fig. 1).
Their retention times made it possible to conclude that
these components had a hydrophobic elution profile
characteristic of peptide metabolites [23]. A positive
biuret reaction with these components confirmed that
the studied metabolites had a peptide nature. The
mass spectrometric analysis of the extract from the
fungal CL (Fig. 2) showed the presence of peaks in the
range of mass-to-charge (m/z) values from 700 to
1500. With further fragmentation of the metabolite
(m/z 885.533), 55 possible variants of the amino acid
composition of the peptides were found. These vari-
ants, in decreasing order of the likelihood of their
presence in CL of T. asperellum F-1087, were as fol-
lows: VRRRKNG, GNZMHWL, TSEHLWL,
TGPRRWL, TSELHWL, GPTRRWL, RVRRKNG,
GNZMHLW, GNCHRWL, GNCRHWL,
GNMZHWL, GNHCRWL, GNRCHWL,
MWLHKNG, WMCFKNG, MWCFKNG,
WMLHKNG, WMSYKNG, MWSYKNG,
Fig. 1. Reversed-phase HPLC of ethyl acetate extracts
from cultural liquid of T. asperellum F-1087.
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TSELHLW, GNRCHLW, GNCRHLW,
GNMZHLW, PGTRRWL, GTPRRWL, GPYLHWL,
GPYHLWL, GVVRRWL, VGVRRWL, PGYLHWL,
RVRRWL, AALRRWL, PGYHLWL, GPYLHLW,
YPGLHWL, YPGHLWL, GLFLHWL, GLFHLWL,
GEMLHWL, GEMHLWL, GMELHWL,
GMEHLWL, GFLLHWL, GFLHLWL, GYPLHWL,
GYPHLWL, YGPLHWL, YGPHLWL, GFLLHLW,
GYPLHLW, YGPLHLW, GEMLHLW, YPGLHLW,
GMELHLW, and GLFLHLW.
Ethylnorvaline (Z), a nonproteinogenic amino acid,
could presumably be a part of some peptides; this amino
acid is a characteristic component of peptaibols. Peptai-
bols are short peptides containing 7–20 amino acid res-
idues, among which there are nonproteinogenic α-ami-
noisobutyric acid, ethylnorvaline, isovaline, or
hydroxyproline [23]. A search of the Peptaibol Data-
base (http://peptaibol.cryst.bbk.ac.uk) showed that the
isolated peptides do not belong to the known peptai-
bols. It can be assumed that they are related to the not
yet identified peptaibols. Secondary metabolites of a
similar species of T. asperellum were studied previously;
their mass spectrometric identification showed that, in
the CL composition, there were peptaibols of the group
of asperylin and trichotoxin possessing antibacterial,
antifungal, and antiviral activity [20, 23].
The effect of peptaibols of T. asperellum F-1087 on
eukaryotic cells of the PC-3 line was studied. It turned
out that they inhibited the metabolic activity of the
cells. Figure 3 shows that the death of PC-3 cell lines
is directly proportional to an increased peptaibol con-
tent in the wells. Maximum inhibition (90%) was
observed at a metabolite concentration of 1.7 mg/mL.
The concentration at which 50% of the cells died
(IC50) was 0.03169 mg/mL. These data supplement
the results of our previous work, in which the effect of
secondary metabolites of T. asperellum F-1087 on cer-
vical and breast cancer cell lines was studied [14].
Fig. 2. Mass spectrum of metabolites isolated from cultural liquid of T. asperellum F-1087.
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Fig. 3. Viability (%) of PC-3 cells under the action of sec-
ondary metabolites from T. asperellum F-1087 at concen-
trations of (1) 1.7, (2) 0.08, (3) 0.04, (4) 0.02, (5) 0.01,
(6) 0.005, (7) 0.002, (8) 0.001, (9) 0.0006, and
(10) 0.0003 mg/mL (MTT assay).
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As a result, it has been found that the secondary
metabolites isolated from CL of T. asperellum F-1087
have a peptide nature similar to peptaibols. Secondary
metabolites of this mold fungus can suppress a wide
range of human cancer cell lines.
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